NVAClass II

Cancer Monitoring Test System, Soluble Mesothelin-Related Peptides, Mesothelioma

21 CFR 866.6010 / Immunology

NVA is the FDA product code for Cancer Monitoring Test System, Soluble Mesothelin-Related Peptides, Mesothelioma, a class II device type, regulated under 21 CFR 866.6010. FDA's definition for this code reads: "MONITORING CANCER PATIENTS AFTER THERAPY FOR DISEASE PROGRESSION IN CONJUNCTION WITH OTHER DIAGNOSTIC MODALITIES". As of 2026-09-10, FDA records hold no 510(k) clearances under this code and no recalls.

Classification record

Product code: NVA
Device name: Cancer Monitoring Test System, Soluble Mesothelin-Related Peptides, Mesothelioma
FDA definition: MONITORING CANCER PATIENTS AFTER THERAPY FOR DISEASE PROGRESSION IN CONJUNCTION WITH OTHER DIAGNOSTIC MODALITIES.
Regulation: 21 CFR 866.6010
Device class: Class II
Review panel: Immunology
Submission type: 510(k)
Implant: No
Life sustaining or supporting: No
GMP exempt: No
Third party review eligible: Yes
Ingested clearances: 0
Ingested recalls: 0

Companies listing this code with FDA

Companies whose registered establishments list this code

No registered establishment in MDM’s records lists product code NVA.

Recent clearances

Product code NVA

FDA records hold no clearances under product code NVA.

Recent recalls

Product code NVA

FDA records show no recalls under product code NVA.

MDM coverage of this record lists here, newest first.

About this record

Sourced from the FDA device classification database, ingested from openFDA. The definition, regulation number, device class and review panel are FDA’s own fields, reproduced without editing.

MDM adds the counts: clearances by decision year, the applicants holding the most clearances under this code, recalls that name it, and the registered establishments that list it. Every count is computed from ingested records only.

Data as of 2026-10-05, the FDA export date for this dataset. Page last changed 2026-09-05. View this product code on fda.gov (opens on fda.gov)